Clinical Trial Update: Zopa Retreatment and Vector Shedding in Adults With RRP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating retreatment with Zopa and monitoring vector shedding in adults with recurrent respiratory papillomatosis is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Respiratory Papillomatosis

Drugs mentioned

• Zopa

Snippet

Sponsor: Precigen, Inc | Conditions: Recurrent Respiratory Papillomatosis, Papillomavirus Infection | Phase 4 | Status: RECRUITING